Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants – Canada NewsWireBy / November 7, 2019 Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants Canada NewsWire Share this:TweetReddit
